PUBLISHER: The Business Research Company | PRODUCT CODE: 2161047
PUBLISHER: The Business Research Company | PRODUCT CODE: 2161047
Medical balloon manufacturing refers to the specialized production of ultra-thin, expandable balloons designed for use with catheter-based medical devices. The manufacturing process incorporates precision polymer processing, forming, and assembly techniques to achieve controlled balloon dimensions, wall thickness, flexibility, and pressure resistance. These balloons are designed to provide reliable expansion and conformability during minimally invasive procedures while meeting stringent performance, quality, and safety requirements.
The primary balloon types in medical balloon manufacturing include angioplasty balloons, stent delivery balloons, drug-coated balloons, occlusion balloons, dilatation balloons, extraction balloons, specialty balloons, and other balloon types. Angioplasty balloons refer to inflatable medical devices designed to dilate narrowed or blocked blood vessels during minimally invasive procedures. These balloons are manufactured from polyamide, polyethylene terephthalate, polyurethane, polyether block amide, and silicone using polymer extrusion, stretch blow molding, balloon forming or thermoforming, laser welding and assembly, and catheter bonding and assembly. The various applications include coronary interventions, peripheral vascular interventions, neurovascular procedures, urology, gastroenterology, pulmonology, and others, and they are used by end users such as medical device manufacturers, contract manufacturing organizations, and research and development organizations.
Tariffs are influencing the medical balloon manufacturing market by increasing the costs of imported specialty polymers, precision manufacturing equipment, catheter components, and production machinery used to manufacture ultra-thin medical balloons. Higher input costs can increase manufacturing expenses and affect the supply and pricing of balloons used in angioplasty, stent delivery, dilatation, and other catheter-based procedures, particularly in regions dependent on imported medical device materials such as North America, Europe, and Asia-Pacific. Polymer-intensive manufacturing and specialized forming and assembly equipment are particularly affected because of their reliance on global supply chains. However, tariffs can also encourage localized material sourcing, domestic manufacturing capabilities, and regional supplier diversification, strengthening long-term supply-chain resilience.
The medical balloon manufacturing market research report is one of a series of new reports from The Business Research Company that provides medical balloon manufacturing market statistics, including medical balloon manufacturing industry global market size, regional shares, competitors with a medical balloon manufacturing market share, detailed medical balloon manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the medical balloon manufacturing industry. This medical balloon manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical balloon manufacturing market size has grown strongly in recent years. It will grow from $0.91 billion in 2025 to $0.97 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increasing adoption of minimally invasive procedures, rising demand for catheter-based medical devices, growing use of angioplasty and dilatation balloons, increasing need for precision medical device components, and growing demand for reliable balloon performance.
The medical balloon manufacturing market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. Growth during the forecast period is anticipated to result from rising demand for next-generation specialty medical balloons, increasing use of advanced polymer materials, growing need for ultra-thin balloon walls, wider adoption of automated balloon manufacturing processes, and increasing demand for high-pressure and high-compliance balloon designs. Major trends during the forecast period include greater adoption of ultra-thin medical balloon designs, rising demand for high-pressure balloon manufacturing, increased use of advanced polymer forming technologies, growing need for precise balloon dimensional control, and wider adoption of highly flexible and conformable balloon structures.
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the medical balloon manufacturing market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including coronary artery disease, heart attack, stroke, heart failure, arrhythmias, and peripheral artery disease. The prevalence of cardiovascular diseases is increasing due to rising rates of hypertension, obesity, physical inactivity, and unhealthy dietary patterns, which contribute to arterial damage and atherosclerosis. Medical balloon manufacturing supports cardiovascular disease management by enabling minimally invasive procedures such as angioplasty and stent placement. These balloons help restore blood flow by expanding narrowed or blocked blood vessels, reducing the need for open surgery and supporting faster patient recovery. For instance, in February 2026, according to the American Heart Association, a US-based nonprofit organization focused on cardiovascular health, six in 10 U.S. adults are projected to have cardiovascular disease by 2050, driven by population aging and increasing cardiovascular risk factors. Additional projections indicate that heart valve disease could double by 2040 and triple by 2060, further increasing the need for cardiovascular interventions and catheter-based treatment technologies. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the medical balloon manufacturing market.
Major companies operating in the medical balloon manufacturing market are concentrating on developing advanced products, such as next-generation intravascular lithotripsy (IVL) catheters, to address unmet clinical requirements related to deliverability, lesion crossing, and balloon repositioning in the treatment of calcified coronary artery disease. Next-generation IVL catheters refer to advanced balloon-based systems that use ultrasonic acoustic pressure waves to fracture hardened calcium while incorporating enhanced shaft flexibility, tapered tips with hydrophilic coatings, and improved balloon deflation for easier navigation and repositioning within tortuous arteries. For instance, in May 2026, Johnson & Johnson, a US-based medical technology company, launched the Shockwave C2 Aero Coronary IVL Catheter, a next-generation balloon-based intravascular lithotripsy catheter designed to enhance deliverability through tortuous coronary anatomy, facilitate the crossing of heavily calcified lesions, and support balloon repositioning. The device incorporates a more flexible balloon material, a tapered tip, a hydrophilic coating, and compact balloon deflation and rewrapping capabilities. These advancements require precise balloon forming, specialized material processing, catheter assembly, and stringent quality-control technologies, thereby supporting innovation in medical balloon manufacturing.
In September 2024, Quasar Medical, a US-based manufacturer of complex minimally invasive medical devices, acquired Ridgeback Technologies Ltd. for an undisclosed amount. The acquisition expanded Quasar Medical's internal capabilities in balloon design, prototyping, mold manufacturing, extrusion, injection molding, and catheter assembly, strengthening its end-to-end medical balloon manufacturing capabilities and supporting faster scale-up and customized balloon catheter production. Ridgeback Technologies Ltd. is a US-based medical device company specializing in the design, development, and manufacture of catheter balloons and complete balloon catheter assemblies.
Major companies operating in the medical balloon manufacturing market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Corporation, Integer Holdings Corporation, B. Braun SE, Cook Group Incorporated, Cordis Corporation, BIOTRONIK SE & Co. KG, Kaneka Corporation, Merit Medical Systems Inc, Lepu Medical Technology (Beijing) Co. Ltd, OrbusNeich Medical Company Ltd, Biomerics LLC, Endologix LLC, BrosMed Medical Co. Ltd, Tokai Medical Products Inc, Hexacath SA, NATEC Medical Ltd, iVascular S.L.U., Balton Sp. z o.o., Concept Medical Inc
North America was the dominating region in the medical balloon manufacturing market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the medical balloon manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical balloon manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical balloon manufacturing consists of sales of cutting balloons, scoring balloons, lithotripsy balloons, perfusion balloons and embolectomy balloons. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream medical device manufacturers, catheter assemblers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Balloon Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical balloon manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical balloon manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical balloon manufacturing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope are limited to 20% of content and consultant support time is limited to 8 hours.